nodes	percent_of_prediction	percent_of_DWPC	metapath
Brimonidine—ADRA2A—epilepsy syndrome	0.391	1	CbGaD
Brimonidine—AOX1—Zonisamide—epilepsy syndrome	0.242	1	CbGbCtD
Brimonidine—Tizanidine—ADRA2A—epilepsy syndrome	0.00121	0.343	CrCbGaD
Brimonidine—Apraclonidine—ADRA2A—epilepsy syndrome	0.00118	0.335	CrCbGaD
Brimonidine—Clonidine—ADRA2A—epilepsy syndrome	0.000591	0.168	CrCbGaD
Brimonidine—Clonidine—CYP2D6—epilepsy syndrome	0.000317	0.0899	CrCbGaD
Brimonidine—Clonidine—ABCB1—epilepsy syndrome	0.000226	0.0642	CrCbGaD
Brimonidine—Pruritus—Vigabatrin—epilepsy syndrome	8.86e-05	0.000366	CcSEcCtD
Brimonidine—Asthenia—Diazepam—epilepsy syndrome	8.84e-05	0.000366	CcSEcCtD
Brimonidine—Pain—Lamotrigine—epilepsy syndrome	8.82e-05	0.000365	CcSEcCtD
Brimonidine—Nausea—Acetazolamide—epilepsy syndrome	8.81e-05	0.000364	CcSEcCtD
Brimonidine—Dizziness—Levetiracetam—epilepsy syndrome	8.8e-05	0.000364	CcSEcCtD
Brimonidine—Cough—Valproic Acid—epilepsy syndrome	8.76e-05	0.000362	CcSEcCtD
Brimonidine—Pruritus—Diazepam—epilepsy syndrome	8.72e-05	0.000361	CcSEcCtD
Brimonidine—Conjunctivitis—Topiramate—epilepsy syndrome	8.71e-05	0.00036	CcSEcCtD
Brimonidine—Rash—Propofol—epilepsy syndrome	8.68e-05	0.000359	CcSEcCtD
Brimonidine—Dermatitis—Propofol—epilepsy syndrome	8.67e-05	0.000359	CcSEcCtD
Brimonidine—Hypertension—Valproic Acid—epilepsy syndrome	8.67e-05	0.000358	CcSEcCtD
Brimonidine—Immune system disorder—Gabapentin—epilepsy syndrome	8.63e-05	0.000357	CcSEcCtD
Brimonidine—Headache—Propofol—epilepsy syndrome	8.63e-05	0.000357	CcSEcCtD
Brimonidine—Mediastinal disorder—Gabapentin—epilepsy syndrome	8.62e-05	0.000356	CcSEcCtD
Brimonidine—Hypersensitivity—Zonisamide—epilepsy syndrome	8.6e-05	0.000356	CcSEcCtD
Brimonidine—Asthenia—Felbamate—epilepsy syndrome	8.56e-05	0.000354	CcSEcCtD
Brimonidine—Vision blurred—Pregabalin—epilepsy syndrome	8.55e-05	0.000354	CcSEcCtD
Brimonidine—Arthralgia—Valproic Acid—epilepsy syndrome	8.55e-05	0.000353	CcSEcCtD
Brimonidine—Myalgia—Valproic Acid—epilepsy syndrome	8.55e-05	0.000353	CcSEcCtD
Brimonidine—Chest pain—Valproic Acid—epilepsy syndrome	8.55e-05	0.000353	CcSEcCtD
Brimonidine—Anxiety—Valproic Acid—epilepsy syndrome	8.52e-05	0.000352	CcSEcCtD
Brimonidine—Rash—Midazolam—epilepsy syndrome	8.49e-05	0.000351	CcSEcCtD
Brimonidine—Dizziness—Fosphenytoin—epilepsy syndrome	8.49e-05	0.000351	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	8.49e-05	0.000351	CcSEcCtD
Brimonidine—Dermatitis—Midazolam—epilepsy syndrome	8.49e-05	0.000351	CcSEcCtD
Brimonidine—Discomfort—Valproic Acid—epilepsy syndrome	8.44e-05	0.000349	CcSEcCtD
Brimonidine—Headache—Midazolam—epilepsy syndrome	8.44e-05	0.000349	CcSEcCtD
Brimonidine—Pruritus—Felbamate—epilepsy syndrome	8.44e-05	0.000349	CcSEcCtD
Brimonidine—Sinusitis—Topiramate—epilepsy syndrome	8.41e-05	0.000348	CcSEcCtD
Brimonidine—Rash—Levetiracetam—epilepsy syndrome	8.39e-05	0.000347	CcSEcCtD
Brimonidine—Dermatitis—Levetiracetam—epilepsy syndrome	8.38e-05	0.000347	CcSEcCtD
Brimonidine—Asthenia—Zonisamide—epilepsy syndrome	8.38e-05	0.000346	CcSEcCtD
Brimonidine—Mental disorder—Gabapentin—epilepsy syndrome	8.38e-05	0.000346	CcSEcCtD
Brimonidine—Dry mouth—Valproic Acid—epilepsy syndrome	8.36e-05	0.000346	CcSEcCtD
Brimonidine—Headache—Levetiracetam—epilepsy syndrome	8.33e-05	0.000345	CcSEcCtD
Brimonidine—Erythema—Gabapentin—epilepsy syndrome	8.32e-05	0.000344	CcSEcCtD
Brimonidine—Hypersensitivity—Clonazepam—epilepsy syndrome	8.29e-05	0.000343	CcSEcCtD
Brimonidine—Dizziness—Vigabatrin—epilepsy syndrome	8.28e-05	0.000342	CcSEcCtD
Brimonidine—Pruritus—Zonisamide—epilepsy syndrome	8.26e-05	0.000342	CcSEcCtD
Brimonidine—Hypersensitivity—Phenytoin—epilepsy syndrome	8.23e-05	0.00034	CcSEcCtD
Brimonidine—Oedema—Valproic Acid—epilepsy syndrome	8.19e-05	0.000339	CcSEcCtD
Brimonidine—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	8.19e-05	0.000339	CcSEcCtD
Brimonidine—Bradycardia—Topiramate—epilepsy syndrome	8.19e-05	0.000339	CcSEcCtD
Brimonidine—Nausea—Propofol—epilepsy syndrome	8.18e-05	0.000338	CcSEcCtD
Brimonidine—Dysgeusia—Gabapentin—epilepsy syndrome	8.15e-05	0.000337	CcSEcCtD
Brimonidine—Dizziness—Diazepam—epilepsy syndrome	8.15e-05	0.000337	CcSEcCtD
Brimonidine—Infection—Valproic Acid—epilepsy syndrome	8.14e-05	0.000337	CcSEcCtD
Brimonidine—Syncope—Pregabalin—epilepsy syndrome	8.14e-05	0.000337	CcSEcCtD
Brimonidine—Rash—Fosphenytoin—epilepsy syndrome	8.1e-05	0.000335	CcSEcCtD
Brimonidine—Dermatitis—Fosphenytoin—epilepsy syndrome	8.09e-05	0.000334	CcSEcCtD
Brimonidine—Asthenia—Clonazepam—epilepsy syndrome	8.07e-05	0.000334	CcSEcCtD
Brimonidine—Rhinitis—Topiramate—epilepsy syndrome	8.06e-05	0.000333	CcSEcCtD
Brimonidine—Headache—Fosphenytoin—epilepsy syndrome	8.04e-05	0.000333	CcSEcCtD
Brimonidine—Nervous system disorder—Valproic Acid—epilepsy syndrome	8.03e-05	0.000332	CcSEcCtD
Brimonidine—Palpitations—Pregabalin—epilepsy syndrome	8.02e-05	0.000332	CcSEcCtD
Brimonidine—Asthenia—Phenytoin—epilepsy syndrome	8.02e-05	0.000332	CcSEcCtD
Brimonidine—Nausea—Midazolam—epilepsy syndrome	8e-05	0.000331	CcSEcCtD
Brimonidine—Tachycardia—Valproic Acid—epilepsy syndrome	8e-05	0.000331	CcSEcCtD
Brimonidine—Pharyngitis—Topiramate—epilepsy syndrome	7.98e-05	0.00033	CcSEcCtD
Brimonidine—Loss of consciousness—Pregabalin—epilepsy syndrome	7.98e-05	0.00033	CcSEcCtD
Brimonidine—Asthenia—Oxcarbazepine—epilepsy syndrome	7.98e-05	0.00033	CcSEcCtD
Brimonidine—Pruritus—Clonazepam—epilepsy syndrome	7.96e-05	0.000329	CcSEcCtD
Brimonidine—Skin disorder—Valproic Acid—epilepsy syndrome	7.96e-05	0.000329	CcSEcCtD
Brimonidine—Cough—Pregabalin—epilepsy syndrome	7.92e-05	0.000327	CcSEcCtD
Brimonidine—Pruritus—Phenytoin—epilepsy syndrome	7.91e-05	0.000327	CcSEcCtD
Brimonidine—Nausea—Levetiracetam—epilepsy syndrome	7.9e-05	0.000327	CcSEcCtD
Brimonidine—Rash—Vigabatrin—epilepsy syndrome	7.89e-05	0.000326	CcSEcCtD
Brimonidine—Dizziness—Felbamate—epilepsy syndrome	7.89e-05	0.000326	CcSEcCtD
Brimonidine—Dermatitis—Vigabatrin—epilepsy syndrome	7.88e-05	0.000326	CcSEcCtD
Brimonidine—Pruritus—Oxcarbazepine—epilepsy syndrome	7.87e-05	0.000325	CcSEcCtD
Brimonidine—Hypersensitivity—Carbamazepine—epilepsy syndrome	7.86e-05	0.000325	CcSEcCtD
Brimonidine—Vision blurred—Gabapentin—epilepsy syndrome	7.84e-05	0.000324	CcSEcCtD
Brimonidine—Headache—Vigabatrin—epilepsy syndrome	7.84e-05	0.000324	CcSEcCtD
Brimonidine—Hypertension—Pregabalin—epilepsy syndrome	7.84e-05	0.000324	CcSEcCtD
Brimonidine—Rash—Diazepam—epilepsy syndrome	7.77e-05	0.000321	CcSEcCtD
Brimonidine—Dermatitis—Diazepam—epilepsy syndrome	7.76e-05	0.000321	CcSEcCtD
Brimonidine—Visual impairment—Topiramate—epilepsy syndrome	7.75e-05	0.00032	CcSEcCtD
Brimonidine—Chest pain—Pregabalin—epilepsy syndrome	7.73e-05	0.000319	CcSEcCtD
Brimonidine—Arthralgia—Pregabalin—epilepsy syndrome	7.73e-05	0.000319	CcSEcCtD
Brimonidine—Myalgia—Pregabalin—epilepsy syndrome	7.73e-05	0.000319	CcSEcCtD
Brimonidine—Dizziness—Zonisamide—epilepsy syndrome	7.72e-05	0.000319	CcSEcCtD
Brimonidine—Headache—Diazepam—epilepsy syndrome	7.72e-05	0.000319	CcSEcCtD
Brimonidine—Anxiety—Pregabalin—epilepsy syndrome	7.7e-05	0.000318	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	7.67e-05	0.000317	CcSEcCtD
Brimonidine—Hypotension—Valproic Acid—epilepsy syndrome	7.66e-05	0.000317	CcSEcCtD
Brimonidine—Asthenia—Carbamazepine—epilepsy syndrome	7.65e-05	0.000316	CcSEcCtD
Brimonidine—Discomfort—Pregabalin—epilepsy syndrome	7.63e-05	0.000316	CcSEcCtD
Brimonidine—Nausea—Fosphenytoin—epilepsy syndrome	7.63e-05	0.000315	CcSEcCtD
Brimonidine—Hypersensitivity—Lamotrigine—epilepsy syndrome	7.6e-05	0.000314	CcSEcCtD
Brimonidine—Dry mouth—Pregabalin—epilepsy syndrome	7.56e-05	0.000312	CcSEcCtD
Brimonidine—Pruritus—Carbamazepine—epilepsy syndrome	7.55e-05	0.000312	CcSEcCtD
Brimonidine—Rash—Felbamate—epilepsy syndrome	7.52e-05	0.000311	CcSEcCtD
Brimonidine—Eye disorder—Topiramate—epilepsy syndrome	7.52e-05	0.000311	CcSEcCtD
Brimonidine—Dermatitis—Felbamate—epilepsy syndrome	7.51e-05	0.000311	CcSEcCtD
Brimonidine—Headache—Felbamate—epilepsy syndrome	7.47e-05	0.000309	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	7.46e-05	0.000309	CcSEcCtD
Brimonidine—Flushing—Topiramate—epilepsy syndrome	7.46e-05	0.000309	CcSEcCtD
Brimonidine—Cardiac disorder—Topiramate—epilepsy syndrome	7.46e-05	0.000309	CcSEcCtD
Brimonidine—Syncope—Gabapentin—epilepsy syndrome	7.46e-05	0.000309	CcSEcCtD
Brimonidine—Dizziness—Clonazepam—epilepsy syndrome	7.44e-05	0.000308	CcSEcCtD
Brimonidine—Nausea—Vigabatrin—epilepsy syndrome	7.43e-05	0.000307	CcSEcCtD
Brimonidine—Insomnia—Valproic Acid—epilepsy syndrome	7.41e-05	0.000306	CcSEcCtD
Brimonidine—Oedema—Pregabalin—epilepsy syndrome	7.41e-05	0.000306	CcSEcCtD
Brimonidine—Asthenia—Lamotrigine—epilepsy syndrome	7.4e-05	0.000306	CcSEcCtD
Brimonidine—Dizziness—Phenytoin—epilepsy syndrome	7.39e-05	0.000306	CcSEcCtD
Brimonidine—Rash—Zonisamide—epilepsy syndrome	7.36e-05	0.000304	CcSEcCtD
Brimonidine—Infection—Pregabalin—epilepsy syndrome	7.36e-05	0.000304	CcSEcCtD
Brimonidine—Paraesthesia—Valproic Acid—epilepsy syndrome	7.36e-05	0.000304	CcSEcCtD
Brimonidine—Palpitations—Gabapentin—epilepsy syndrome	7.35e-05	0.000304	CcSEcCtD
Brimonidine—Dermatitis—Zonisamide—epilepsy syndrome	7.35e-05	0.000304	CcSEcCtD
Brimonidine—Dizziness—Oxcarbazepine—epilepsy syndrome	7.35e-05	0.000304	CcSEcCtD
Brimonidine—Nausea—Diazepam—epilepsy syndrome	7.32e-05	0.000303	CcSEcCtD
Brimonidine—Loss of consciousness—Gabapentin—epilepsy syndrome	7.31e-05	0.000302	CcSEcCtD
Brimonidine—Headache—Zonisamide—epilepsy syndrome	7.31e-05	0.000302	CcSEcCtD
Brimonidine—Dyspnoea—Valproic Acid—epilepsy syndrome	7.3e-05	0.000302	CcSEcCtD
Brimonidine—Angiopathy—Topiramate—epilepsy syndrome	7.3e-05	0.000302	CcSEcCtD
Brimonidine—Pruritus—Lamotrigine—epilepsy syndrome	7.29e-05	0.000302	CcSEcCtD
Brimonidine—Shock—Pregabalin—epilepsy syndrome	7.29e-05	0.000301	CcSEcCtD
Brimonidine—Somnolence—Valproic Acid—epilepsy syndrome	7.28e-05	0.000301	CcSEcCtD
Brimonidine—Immune system disorder—Topiramate—epilepsy syndrome	7.26e-05	0.0003	CcSEcCtD
Brimonidine—Nervous system disorder—Pregabalin—epilepsy syndrome	7.26e-05	0.0003	CcSEcCtD
Brimonidine—Cough—Gabapentin—epilepsy syndrome	7.26e-05	0.0003	CcSEcCtD
Brimonidine—Mediastinal disorder—Topiramate—epilepsy syndrome	7.25e-05	0.0003	CcSEcCtD
Brimonidine—Tachycardia—Pregabalin—epilepsy syndrome	7.23e-05	0.000299	CcSEcCtD
Brimonidine—Dyspepsia—Valproic Acid—epilepsy syndrome	7.21e-05	0.000298	CcSEcCtD
Brimonidine—Skin disorder—Pregabalin—epilepsy syndrome	7.19e-05	0.000297	CcSEcCtD
Brimonidine—Hypertension—Gabapentin—epilepsy syndrome	7.18e-05	0.000297	CcSEcCtD
Brimonidine—Rash—Clonazepam—epilepsy syndrome	7.09e-05	0.000293	CcSEcCtD
Brimonidine—Dermatitis—Clonazepam—epilepsy syndrome	7.09e-05	0.000293	CcSEcCtD
Brimonidine—Myalgia—Gabapentin—epilepsy syndrome	7.08e-05	0.000293	CcSEcCtD
Brimonidine—Chest pain—Gabapentin—epilepsy syndrome	7.08e-05	0.000293	CcSEcCtD
Brimonidine—Arthralgia—Gabapentin—epilepsy syndrome	7.08e-05	0.000293	CcSEcCtD
Brimonidine—Nausea—Felbamate—epilepsy syndrome	7.08e-05	0.000293	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	7.07e-05	0.000292	CcSEcCtD
Brimonidine—Fatigue—Valproic Acid—epilepsy syndrome	7.06e-05	0.000292	CcSEcCtD
Brimonidine—Anxiety—Gabapentin—epilepsy syndrome	7.06e-05	0.000292	CcSEcCtD
Brimonidine—Dizziness—Carbamazepine—epilepsy syndrome	7.05e-05	0.000292	CcSEcCtD
Brimonidine—Headache—Clonazepam—epilepsy syndrome	7.05e-05	0.000291	CcSEcCtD
Brimonidine—Rash—Phenytoin—epilepsy syndrome	7.05e-05	0.000291	CcSEcCtD
Brimonidine—Mental disorder—Topiramate—epilepsy syndrome	7.05e-05	0.000291	CcSEcCtD
Brimonidine—Dermatitis—Phenytoin—epilepsy syndrome	7.04e-05	0.000291	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	7.04e-05	0.000291	CcSEcCtD
Brimonidine—Rash—Oxcarbazepine—epilepsy syndrome	7.01e-05	0.00029	CcSEcCtD
Brimonidine—Pain—Valproic Acid—epilepsy syndrome	7.01e-05	0.00029	CcSEcCtD
Brimonidine—Dermatitis—Oxcarbazepine—epilepsy syndrome	7e-05	0.00029	CcSEcCtD
Brimonidine—Headache—Phenytoin—epilepsy syndrome	7e-05	0.00029	CcSEcCtD
Brimonidine—Erythema—Topiramate—epilepsy syndrome	7e-05	0.00029	CcSEcCtD
Brimonidine—Discomfort—Gabapentin—epilepsy syndrome	7e-05	0.000289	CcSEcCtD
Brimonidine—Headache—Oxcarbazepine—epilepsy syndrome	6.96e-05	0.000288	CcSEcCtD
Brimonidine—Nausea—Zonisamide—epilepsy syndrome	6.93e-05	0.000287	CcSEcCtD
Brimonidine—Dry mouth—Gabapentin—epilepsy syndrome	6.93e-05	0.000287	CcSEcCtD
Brimonidine—Hypotension—Pregabalin—epilepsy syndrome	6.92e-05	0.000286	CcSEcCtD
Brimonidine—Dysgeusia—Topiramate—epilepsy syndrome	6.86e-05	0.000284	CcSEcCtD
Brimonidine—Dizziness—Lamotrigine—epilepsy syndrome	6.82e-05	0.000282	CcSEcCtD
Brimonidine—Oedema—Gabapentin—epilepsy syndrome	6.79e-05	0.000281	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	6.75e-05	0.000279	CcSEcCtD
Brimonidine—Infection—Gabapentin—epilepsy syndrome	6.75e-05	0.000279	CcSEcCtD
Brimonidine—Rash—Carbamazepine—epilepsy syndrome	6.73e-05	0.000278	CcSEcCtD
Brimonidine—Dermatitis—Carbamazepine—epilepsy syndrome	6.72e-05	0.000278	CcSEcCtD
Brimonidine—Insomnia—Pregabalin—epilepsy syndrome	6.7e-05	0.000277	CcSEcCtD
Brimonidine—Nausea—Clonazepam—epilepsy syndrome	6.68e-05	0.000276	CcSEcCtD
Brimonidine—Headache—Carbamazepine—epilepsy syndrome	6.68e-05	0.000276	CcSEcCtD
Brimonidine—Shock—Gabapentin—epilepsy syndrome	6.68e-05	0.000276	CcSEcCtD
Brimonidine—Nervous system disorder—Gabapentin—epilepsy syndrome	6.66e-05	0.000275	CcSEcCtD
Brimonidine—Paraesthesia—Pregabalin—epilepsy syndrome	6.65e-05	0.000275	CcSEcCtD
Brimonidine—Nausea—Phenytoin—epilepsy syndrome	6.64e-05	0.000274	CcSEcCtD
Brimonidine—Tachycardia—Gabapentin—epilepsy syndrome	6.63e-05	0.000274	CcSEcCtD
Brimonidine—Dyspnoea—Pregabalin—epilepsy syndrome	6.6e-05	0.000273	CcSEcCtD
Brimonidine—Nausea—Oxcarbazepine—epilepsy syndrome	6.6e-05	0.000273	CcSEcCtD
Brimonidine—Vision blurred—Topiramate—epilepsy syndrome	6.6e-05	0.000273	CcSEcCtD
Brimonidine—Skin disorder—Gabapentin—epilepsy syndrome	6.6e-05	0.000273	CcSEcCtD
Brimonidine—Somnolence—Pregabalin—epilepsy syndrome	6.58e-05	0.000272	CcSEcCtD
Brimonidine—Rash—Lamotrigine—epilepsy syndrome	6.5e-05	0.000269	CcSEcCtD
Brimonidine—Dermatitis—Lamotrigine—epilepsy syndrome	6.49e-05	0.000269	CcSEcCtD
Brimonidine—Headache—Lamotrigine—epilepsy syndrome	6.46e-05	0.000267	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	6.39e-05	0.000264	CcSEcCtD
Brimonidine—Fatigue—Pregabalin—epilepsy syndrome	6.39e-05	0.000264	CcSEcCtD
Brimonidine—Hypotension—Gabapentin—epilepsy syndrome	6.35e-05	0.000262	CcSEcCtD
Brimonidine—Nausea—Carbamazepine—epilepsy syndrome	6.34e-05	0.000262	CcSEcCtD
Brimonidine—Pain—Pregabalin—epilepsy syndrome	6.33e-05	0.000262	CcSEcCtD
Brimonidine—Syncope—Topiramate—epilepsy syndrome	6.28e-05	0.00026	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	6.19e-05	0.000256	CcSEcCtD
Brimonidine—Palpitations—Topiramate—epilepsy syndrome	6.19e-05	0.000256	CcSEcCtD
Brimonidine—Loss of consciousness—Topiramate—epilepsy syndrome	6.15e-05	0.000254	CcSEcCtD
Brimonidine—Insomnia—Gabapentin—epilepsy syndrome	6.14e-05	0.000254	CcSEcCtD
Brimonidine—Nausea—Lamotrigine—epilepsy syndrome	6.12e-05	0.000253	CcSEcCtD
Brimonidine—Cough—Topiramate—epilepsy syndrome	6.11e-05	0.000253	CcSEcCtD
Brimonidine—Paraesthesia—Gabapentin—epilepsy syndrome	6.1e-05	0.000252	CcSEcCtD
Brimonidine—Dyspnoea—Gabapentin—epilepsy syndrome	6.06e-05	0.00025	CcSEcCtD
Brimonidine—Hypertension—Topiramate—epilepsy syndrome	6.04e-05	0.00025	CcSEcCtD
Brimonidine—Somnolence—Gabapentin—epilepsy syndrome	6.04e-05	0.00025	CcSEcCtD
Brimonidine—Hypersensitivity—Valproic Acid—epilepsy syndrome	6.04e-05	0.00025	CcSEcCtD
Brimonidine—Dyspepsia—Gabapentin—epilepsy syndrome	5.98e-05	0.000247	CcSEcCtD
Brimonidine—Arthralgia—Topiramate—epilepsy syndrome	5.96e-05	0.000246	CcSEcCtD
Brimonidine—Myalgia—Topiramate—epilepsy syndrome	5.96e-05	0.000246	CcSEcCtD
Brimonidine—Chest pain—Topiramate—epilepsy syndrome	5.96e-05	0.000246	CcSEcCtD
Brimonidine—Anxiety—Topiramate—epilepsy syndrome	5.94e-05	0.000246	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	5.92e-05	0.000245	CcSEcCtD
Brimonidine—Discomfort—Topiramate—epilepsy syndrome	5.89e-05	0.000244	CcSEcCtD
Brimonidine—Asthenia—Valproic Acid—epilepsy syndrome	5.88e-05	0.000243	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	5.86e-05	0.000242	CcSEcCtD
Brimonidine—Fatigue—Gabapentin—epilepsy syndrome	5.86e-05	0.000242	CcSEcCtD
Brimonidine—Dry mouth—Topiramate—epilepsy syndrome	5.83e-05	0.000241	CcSEcCtD
Brimonidine—Pain—Gabapentin—epilepsy syndrome	5.81e-05	0.00024	CcSEcCtD
Brimonidine—Pruritus—Valproic Acid—epilepsy syndrome	5.8e-05	0.00024	CcSEcCtD
Brimonidine—Oedema—Topiramate—epilepsy syndrome	5.71e-05	0.000236	CcSEcCtD
Brimonidine—Infection—Topiramate—epilepsy syndrome	5.68e-05	0.000235	CcSEcCtD
Brimonidine—Shock—Topiramate—epilepsy syndrome	5.62e-05	0.000232	CcSEcCtD
Brimonidine—Nervous system disorder—Topiramate—epilepsy syndrome	5.6e-05	0.000232	CcSEcCtD
Brimonidine—Tachycardia—Topiramate—epilepsy syndrome	5.58e-05	0.000231	CcSEcCtD
Brimonidine—Skin disorder—Topiramate—epilepsy syndrome	5.55e-05	0.00023	CcSEcCtD
Brimonidine—Hypersensitivity—Pregabalin—epilepsy syndrome	5.46e-05	0.000226	CcSEcCtD
Brimonidine—Dizziness—Valproic Acid—epilepsy syndrome	5.42e-05	0.000224	CcSEcCtD
Brimonidine—Hypotension—Topiramate—epilepsy syndrome	5.34e-05	0.000221	CcSEcCtD
Brimonidine—Asthenia—Pregabalin—epilepsy syndrome	5.31e-05	0.00022	CcSEcCtD
Brimonidine—Pruritus—Pregabalin—epilepsy syndrome	5.24e-05	0.000217	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	5.21e-05	0.000215	CcSEcCtD
Brimonidine—Insomnia—Topiramate—epilepsy syndrome	5.17e-05	0.000214	CcSEcCtD
Brimonidine—Rash—Valproic Acid—epilepsy syndrome	5.17e-05	0.000214	CcSEcCtD
Brimonidine—Dermatitis—Valproic Acid—epilepsy syndrome	5.16e-05	0.000213	CcSEcCtD
Brimonidine—Headache—Valproic Acid—epilepsy syndrome	5.13e-05	0.000212	CcSEcCtD
Brimonidine—Paraesthesia—Topiramate—epilepsy syndrome	5.13e-05	0.000212	CcSEcCtD
Brimonidine—Dyspnoea—Topiramate—epilepsy syndrome	5.09e-05	0.000211	CcSEcCtD
Brimonidine—Somnolence—Topiramate—epilepsy syndrome	5.08e-05	0.00021	CcSEcCtD
Brimonidine—Dyspepsia—Topiramate—epilepsy syndrome	5.03e-05	0.000208	CcSEcCtD
Brimonidine—Hypersensitivity—Gabapentin—epilepsy syndrome	5e-05	0.000207	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	4.93e-05	0.000204	CcSEcCtD
Brimonidine—Fatigue—Topiramate—epilepsy syndrome	4.93e-05	0.000204	CcSEcCtD
Brimonidine—Dizziness—Pregabalin—epilepsy syndrome	4.9e-05	0.000203	CcSEcCtD
Brimonidine—Pain—Topiramate—epilepsy syndrome	4.89e-05	0.000202	CcSEcCtD
Brimonidine—Asthenia—Gabapentin—epilepsy syndrome	4.87e-05	0.000201	CcSEcCtD
Brimonidine—Nausea—Valproic Acid—epilepsy syndrome	4.87e-05	0.000201	CcSEcCtD
Brimonidine—Pruritus—Gabapentin—epilepsy syndrome	4.81e-05	0.000199	CcSEcCtD
Brimonidine—Rash—Pregabalin—epilepsy syndrome	4.67e-05	0.000193	CcSEcCtD
Brimonidine—Dermatitis—Pregabalin—epilepsy syndrome	4.67e-05	0.000193	CcSEcCtD
Brimonidine—Headache—Pregabalin—epilepsy syndrome	4.64e-05	0.000192	CcSEcCtD
Brimonidine—Dizziness—Gabapentin—epilepsy syndrome	4.49e-05	0.000186	CcSEcCtD
Brimonidine—Nausea—Pregabalin—epilepsy syndrome	4.4e-05	0.000182	CcSEcCtD
Brimonidine—Rash—Gabapentin—epilepsy syndrome	4.28e-05	0.000177	CcSEcCtD
Brimonidine—Dermatitis—Gabapentin—epilepsy syndrome	4.28e-05	0.000177	CcSEcCtD
Brimonidine—Headache—Gabapentin—epilepsy syndrome	4.25e-05	0.000176	CcSEcCtD
Brimonidine—Hypersensitivity—Topiramate—epilepsy syndrome	4.21e-05	0.000174	CcSEcCtD
Brimonidine—Asthenia—Topiramate—epilepsy syndrome	4.1e-05	0.00017	CcSEcCtD
Brimonidine—Pruritus—Topiramate—epilepsy syndrome	4.04e-05	0.000167	CcSEcCtD
Brimonidine—Nausea—Gabapentin—epilepsy syndrome	4.03e-05	0.000167	CcSEcCtD
Brimonidine—Dizziness—Topiramate—epilepsy syndrome	3.78e-05	0.000156	CcSEcCtD
Brimonidine—Rash—Topiramate—epilepsy syndrome	3.6e-05	0.000149	CcSEcCtD
Brimonidine—Dermatitis—Topiramate—epilepsy syndrome	3.6e-05	0.000149	CcSEcCtD
Brimonidine—Headache—Topiramate—epilepsy syndrome	3.58e-05	0.000148	CcSEcCtD
Brimonidine—Nausea—Topiramate—epilepsy syndrome	3.39e-05	0.00014	CcSEcCtD
Brimonidine—ADRA2A—Signaling Pathways—CHRM3—epilepsy syndrome	1.29e-05	0.000107	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—GRM5—epilepsy syndrome	1.29e-05	0.000107	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—ADRA2A—epilepsy syndrome	1.29e-05	0.000106	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—CCR5—epilepsy syndrome	1.29e-05	0.000106	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—BCHE—epilepsy syndrome	1.29e-05	0.000106	CbGpPWpGaD
Brimonidine—ADRA2C—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	1.27e-05	0.000105	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—AVP—epilepsy syndrome	1.27e-05	0.000104	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—NPY—epilepsy syndrome	1.26e-05	0.000104	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—ATP2A2—epilepsy syndrome	1.26e-05	0.000104	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—HTR2A—epilepsy syndrome	1.26e-05	0.000104	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—ABCG2—epilepsy syndrome	1.26e-05	0.000104	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CX3CR1—epilepsy syndrome	1.24e-05	0.000102	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—AGT—epilepsy syndrome	1.23e-05	0.000101	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—CYP2C19—epilepsy syndrome	1.23e-05	0.000101	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—SLC2A1—epilepsy syndrome	1.23e-05	0.000101	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—CYP11A1—epilepsy syndrome	1.22e-05	0.000101	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CRH—epilepsy syndrome	1.22e-05	0.000101	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CXCL2—epilepsy syndrome	1.22e-05	0.000101	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—OXT—epilepsy syndrome	1.22e-05	0.000101	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—HSPB1—epilepsy syndrome	1.22e-05	0.000101	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CCL3—epilepsy syndrome	1.22e-05	0.000101	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.22e-05	0.0001	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CX3CL1—epilepsy syndrome	1.22e-05	0.0001	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CHRM2—epilepsy syndrome	1.22e-05	0.0001	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—BDKRB1—epilepsy syndrome	1.22e-05	0.0001	CbGpPWpGaD
Brimonidine—AOX1—Metabolism—PTGS2—epilepsy syndrome	1.22e-05	0.0001	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—TSC1—epilepsy syndrome	1.21e-05	0.0001	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—PTK2B—epilepsy syndrome	1.21e-05	0.0001	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—ALB—epilepsy syndrome	1.21e-05	0.0001	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—PLCB1—epilepsy syndrome	1.21e-05	0.0001	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—TH—epilepsy syndrome	1.21e-05	9.97e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—CCR5—epilepsy syndrome	1.2e-05	9.93e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—AGT—epilepsy syndrome	1.2e-05	9.87e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—CDC42—epilepsy syndrome	1.19e-05	9.79e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—GABBR1—epilepsy syndrome	1.18e-05	9.75e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—NTRK2—epilepsy syndrome	1.18e-05	9.74e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CCR2—epilepsy syndrome	1.18e-05	9.74e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—SST—epilepsy syndrome	1.18e-05	9.74e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—HTR2A—epilepsy syndrome	1.18e-05	9.71e-05	CbGpPWpGaD
Brimonidine—AOX1—Disease—SRC—epilepsy syndrome	1.17e-05	9.68e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—DUSP6—epilepsy syndrome	1.17e-05	9.66e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—ADRA2A—epilepsy syndrome	1.16e-05	9.53e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—PLAT—epilepsy syndrome	1.15e-05	9.49e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—AVP—epilepsy syndrome	1.15e-05	9.48e-05	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.14e-05	9.38e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—TSC1—epilepsy syndrome	1.13e-05	9.35e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—PTK2B—epilepsy syndrome	1.13e-05	9.35e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—HRH3—epilepsy syndrome	1.13e-05	9.35e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Hemostasis—SRC—epilepsy syndrome	1.13e-05	9.34e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—AGT—epilepsy syndrome	1.12e-05	9.22e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—OPRM1—epilepsy syndrome	1.12e-05	9.2e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CXCL12—epilepsy syndrome	1.11e-05	9.16e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—BDKRB2—epilepsy syndrome	1.11e-05	9.16e-05	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—POMC—epilepsy syndrome	1.11e-05	9.15e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—PRKCB—epilepsy syndrome	1.11e-05	9.12e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—SST—epilepsy syndrome	1.1e-05	9.1e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—NTRK2—epilepsy syndrome	1.1e-05	9.1e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CCR2—epilepsy syndrome	1.1e-05	9.1e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Hemostasis—VEGFA—epilepsy syndrome	1.1e-05	9.09e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—CYP2D6—epilepsy syndrome	1.1e-05	9.09e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—IL6ST—epilepsy syndrome	1.1e-05	9.08e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—DUSP6—epilepsy syndrome	1.09e-05	9.02e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—JUNB—epilepsy syndrome	1.09e-05	8.99e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CNR1—epilepsy syndrome	1.09e-05	8.99e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—PLCB1—epilepsy syndrome	1.09e-05	8.96e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—ADRA2A—epilepsy syndrome	1.08e-05	8.9e-05	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—CCR5—epilepsy syndrome	1.08e-05	8.88e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—PLAT—epilepsy syndrome	1.08e-05	8.87e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—HTR7—epilepsy syndrome	1.06e-05	8.77e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—SRC—epilepsy syndrome	1.06e-05	8.72e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CCR3—epilepsy syndrome	1.05e-05	8.69e-05	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.05e-05	8.69e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—BCHE—epilepsy syndrome	1.04e-05	8.61e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—BDKRB2—epilepsy syndrome	1.04e-05	8.56e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CXCL12—epilepsy syndrome	1.04e-05	8.56e-05	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—POMC—epilepsy syndrome	1.04e-05	8.54e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	1.04e-05	8.54e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—PRKCB—epilepsy syndrome	1.03e-05	8.52e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—HBEGF—epilepsy syndrome	1.03e-05	8.51e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—VEGFA—epilepsy syndrome	1.03e-05	8.49e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—IL6ST—epilepsy syndrome	1.03e-05	8.48e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—NPY—epilepsy syndrome	1.03e-05	8.47e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—ATP2A2—epilepsy syndrome	1.03e-05	8.47e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CNR1—epilepsy syndrome	1.02e-05	8.4e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—JUNB—epilepsy syndrome	1.02e-05	8.4e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—PLCB1—epilepsy syndrome	1.01e-05	8.37e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—AKT3—epilepsy syndrome	1.01e-05	8.36e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—HMOX1—epilepsy syndrome	1.01e-05	8.32e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—POMC—epilepsy syndrome	1.01e-05	8.31e-05	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—AGT—epilepsy syndrome	1e-05	8.24e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—SLC2A1—epilepsy syndrome	9.96e-06	8.22e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—CAT—epilepsy syndrome	9.96e-06	8.21e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—HTR7—epilepsy syndrome	9.93e-06	8.19e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—HSPB1—epilepsy syndrome	9.91e-06	8.17e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—OXT—epilepsy syndrome	9.91e-06	8.17e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CRH—epilepsy syndrome	9.91e-06	8.17e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CXCL2—epilepsy syndrome	9.91e-06	8.17e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CCL3—epilepsy syndrome	9.91e-06	8.17e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—ADAM10—epilepsy syndrome	9.9e-06	8.16e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—PLCB1—epilepsy syndrome	9.85e-06	8.13e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—CCL2—epilepsy syndrome	9.85e-06	8.13e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—TH—epilepsy syndrome	9.82e-06	8.1e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—CCR5—epilepsy syndrome	9.78e-06	8.06e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—ABCB1—epilepsy syndrome	9.68e-06	7.99e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—HBEGF—epilepsy syndrome	9.64e-06	7.95e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—HTR2A—epilepsy syndrome	9.57e-06	7.89e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—AKT3—epilepsy syndrome	9.47e-06	7.81e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—POMC—epilepsy syndrome	9.41e-06	7.76e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—S100B—epilepsy syndrome	9.36e-06	7.72e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—SOCS3—epilepsy syndrome	9.27e-06	7.64e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CDC42—epilepsy syndrome	9.25e-06	7.63e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—ADAM10—epilepsy syndrome	9.25e-06	7.63e-05	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—PRKCB—epilepsy syndrome	9.24e-06	7.62e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—TSC1—epilepsy syndrome	9.21e-06	7.6e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PTK2B—epilepsy syndrome	9.21e-06	7.6e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—CCL2—epilepsy syndrome	9.2e-06	7.59e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—AGT—epilepsy syndrome	9.08e-06	7.49e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—GPX1—epilepsy syndrome	9e-06	7.43e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—SST—epilepsy syndrome	8.96e-06	7.39e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—NTRK2—epilepsy syndrome	8.96e-06	7.39e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CCR2—epilepsy syndrome	8.96e-06	7.39e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—AVP—epilepsy syndrome	8.95e-06	7.38e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—DUSP6—epilepsy syndrome	8.88e-06	7.33e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—S100B—epilepsy syndrome	8.74e-06	7.21e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PLAT—epilepsy syndrome	8.73e-06	7.2e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—SOCS3—epilepsy syndrome	8.66e-06	7.14e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CDC42—epilepsy syndrome	8.64e-06	7.12e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—SRC—epilepsy syndrome	8.59e-06	7.08e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—HES1—epilepsy syndrome	8.46e-06	6.98e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CXCL12—epilepsy syndrome	8.43e-06	6.95e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—BDKRB2—epilepsy syndrome	8.43e-06	6.95e-05	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—POMC—epilepsy syndrome	8.41e-06	6.94e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—PRKCB—epilepsy syndrome	8.39e-06	6.92e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—VEGFA—epilepsy syndrome	8.36e-06	6.9e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—AVP—epilepsy syndrome	8.36e-06	6.9e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—IL6ST—epilepsy syndrome	8.35e-06	6.89e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—JUNB—epilepsy syndrome	8.27e-06	6.82e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CNR1—epilepsy syndrome	8.27e-06	6.82e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PLCB1—epilepsy syndrome	8.24e-06	6.8e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—FYN—epilepsy syndrome	8.23e-06	6.79e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—H2AFX—epilepsy syndrome	8.2e-06	6.76e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—HMOX1—epilepsy syndrome	8.2e-06	6.76e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—MEF2C—epilepsy syndrome	8.19e-06	6.75e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—CAT—epilepsy syndrome	8.09e-06	6.67e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—HTR7—epilepsy syndrome	8.07e-06	6.65e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—YWHAZ—epilepsy syndrome	7.91e-06	6.53e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—HES1—epilepsy syndrome	7.91e-06	6.52e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—AGT—epilepsy syndrome	7.89e-06	6.51e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—ABCB1—epilepsy syndrome	7.87e-06	6.49e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—HBEGF—epilepsy syndrome	7.83e-06	6.46e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—NGF—epilepsy syndrome	7.82e-06	6.45e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—APOE—epilepsy syndrome	7.74e-06	6.38e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—FYN—epilepsy syndrome	7.69e-06	6.34e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—AKT3—epilepsy syndrome	7.69e-06	6.34e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—H2AFX—epilepsy syndrome	7.66e-06	6.32e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—MEF2C—epilepsy syndrome	7.65e-06	6.31e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—POMC—epilepsy syndrome	7.64e-06	6.3e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CCR5—epilepsy syndrome	7.61e-06	6.28e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—ADAM10—epilepsy syndrome	7.51e-06	6.19e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—CCL2—epilepsy syndrome	7.48e-06	6.17e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—HTR2A—epilepsy syndrome	7.45e-06	6.14e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—YWHAZ—epilepsy syndrome	7.39e-06	6.1e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—GPX1—epilepsy syndrome	7.31e-06	6.03e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—NGF—epilepsy syndrome	7.31e-06	6.03e-05	CbGpPWpGaD
Brimonidine—AOX1—Disease—AKT1—epilepsy syndrome	7.29e-06	6.02e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CCR5—epilepsy syndrome	7.11e-06	5.86e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—S100B—epilepsy syndrome	7.1e-06	5.86e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—TSC2—epilepsy syndrome	7.08e-06	5.84e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—AGT—epilepsy syndrome	7.07e-06	5.83e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Hemostasis—AKT1—epilepsy syndrome	7.03e-06	5.8e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—SOCS3—epilepsy syndrome	7.03e-06	5.8e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CDC42—epilepsy syndrome	7.02e-06	5.79e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—HTR2A—epilepsy syndrome	6.96e-06	5.74e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—APOE—epilepsy syndrome	6.92e-06	5.71e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—AVP—epilepsy syndrome	6.79e-06	5.6e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—KDR—epilepsy syndrome	6.78e-06	5.6e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—POMC—epilepsy syndrome	6.65e-06	5.48e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—TSC2—epilepsy syndrome	6.61e-06	5.45e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—AGT—epilepsy syndrome	6.6e-06	5.44e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—AKT1—epilepsy syndrome	6.57e-06	5.42e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—PRKCB—epilepsy syndrome	6.53e-06	5.39e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—IL6ST—epilepsy syndrome	6.5e-06	5.36e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—APOE—epilepsy syndrome	6.47e-06	5.33e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—HES1—epilepsy syndrome	6.42e-06	5.3e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—AGT—epilepsy syndrome	6.41e-06	5.29e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—KDR—epilepsy syndrome	6.34e-06	5.23e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—APOE—epilepsy syndrome	6.28e-06	5.18e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—FYN—epilepsy syndrome	6.25e-06	5.15e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—H2AFX—epilepsy syndrome	6.22e-06	5.13e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—MEF2C—epilepsy syndrome	6.21e-06	5.12e-05	CbGpPWpGaD
Brimonidine—AOX1—Metabolism—AKT1—epilepsy syndrome	6.11e-06	5.04e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—PRKCB—epilepsy syndrome	6.1e-06	5.03e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—IL6ST—epilepsy syndrome	6.08e-06	5.01e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—ALB—epilepsy syndrome	6.06e-06	5e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—YWHAZ—epilepsy syndrome	6e-06	4.95e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—POMC—epilepsy syndrome	5.95e-06	4.91e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—NGF—epilepsy syndrome	5.94e-06	4.9e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CCL2—epilepsy syndrome	5.82e-06	4.8e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CCR5—epilepsy syndrome	5.77e-06	4.76e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—HTR2A—epilepsy syndrome	5.65e-06	4.66e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—POMC—epilepsy syndrome	5.56e-06	4.58e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CCL2—epilepsy syndrome	5.44e-06	4.48e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—POMC—epilepsy syndrome	5.4e-06	4.45e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—TSC2—epilepsy syndrome	5.37e-06	4.43e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—AGT—epilepsy syndrome	5.36e-06	4.42e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—AKT1—epilepsy syndrome	5.34e-06	4.4e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—PTGS2—epilepsy syndrome	5.3e-06	4.37e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—FGF2—epilepsy syndrome	5.26e-06	4.34e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—APOE—epilepsy syndrome	5.25e-06	4.33e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—KDR—epilepsy syndrome	5.15e-06	4.25e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PRKCB—epilepsy syndrome	4.95e-06	4.09e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—IL6ST—epilepsy syndrome	4.93e-06	4.07e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—ALB—epilepsy syndrome	4.92e-06	4.06e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—FGF2—epilepsy syndrome	4.91e-06	4.05e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—RELA—epilepsy syndrome	4.88e-06	4.03e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—MTOR—epilepsy syndrome	4.79e-06	3.95e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—RELA—epilepsy syndrome	4.56e-06	3.76e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—POMC—epilepsy syndrome	4.51e-06	3.72e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—MTOR—epilepsy syndrome	4.47e-06	3.69e-05	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—AKT1—epilepsy syndrome	4.45e-06	3.67e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CCL2—epilepsy syndrome	4.42e-06	3.64e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CASP3—epilepsy syndrome	4.4e-06	3.63e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—PTGS2—epilepsy syndrome	4.31e-06	3.55e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—JUN—epilepsy syndrome	4.28e-06	3.53e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—MMP9—epilepsy syndrome	4.16e-06	3.43e-05	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—AKT1—epilepsy syndrome	4.15e-06	3.42e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CASP3—epilepsy syndrome	4.11e-06	3.39e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—AKT1—epilepsy syndrome	4.04e-06	3.33e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—JUN—epilepsy syndrome	4e-06	3.3e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—FGF2—epilepsy syndrome	3.99e-06	3.29e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—MMP9—epilepsy syndrome	3.89e-06	3.21e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—SRC—epilepsy syndrome	3.84e-06	3.16e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—AKT1—epilepsy syndrome	3.77e-06	3.11e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—VEGFA—epilepsy syndrome	3.74e-06	3.08e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—RELA—epilepsy syndrome	3.7e-06	3.06e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—MTOR—epilepsy syndrome	3.63e-06	3e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—SRC—epilepsy syndrome	3.58e-06	2.96e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—VEGFA—epilepsy syndrome	3.49e-06	2.88e-05	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	3.37e-06	2.78e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CASP3—epilepsy syndrome	3.34e-06	2.76e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—JUN—epilepsy syndrome	3.25e-06	2.68e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—MMP9—epilepsy syndrome	3.16e-06	2.6e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—AKT1—epilepsy syndrome	3.06e-06	2.53e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—SRC—epilepsy syndrome	2.91e-06	2.4e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—VEGFA—epilepsy syndrome	2.84e-06	2.34e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—AKT1—epilepsy syndrome	2.66e-06	2.2e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—AKT1—epilepsy syndrome	2.38e-06	1.97e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—AKT1—epilepsy syndrome	2.23e-06	1.84e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—AKT1—epilepsy syndrome	2.16e-06	1.78e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—AKT1—epilepsy syndrome	1.81e-06	1.49e-05	CbGpPWpGaD
